Skip to main content
Help us understand how you use our websites. Take part in our 30 minute study now.

Temperature integrity and exposure of vaccines to suboptimal temperatures in cold chain devices at different levels in three states of India



To document the temperature integrity at the vaccine storage devices at various levels in three states of India.


A total of 213 health facilities including 196 facilities (district and sub-district levels) from 27 select districts and 17 division or state level vaccine stores in three states were included. At these facilities, temperature in 223 vaccine storage devices was recorded for at least 7 consecutive days using electronic temperature datalogger.


During the observation period, overall the vaccines were exposed to temperature < 0 °C for 14.8% of the storage time with 8.6, 6.7 and 18% at state/division, district and sub-district vaccine stores, respectively. The vaccines were also exposed to temperature > 8 °C for 6.6% of the storage time including 1.3, 13 and 5.1% at state/division, district and sub-district vaccine stores, respectively. Continuous episodes of temperature deviation for 45 min or longer to < 0 °C and > 8 °C was observed in 7.2 and 6.4% of the observation period, respectively. These temperature deviations were not captured by the routine temperature monitoring practice.


The vaccines were exposed to freezing temperature for a considerable period at all level stores, which was more than the exposure to higher temperature. To ensure vaccine potency and immunogenicity, stringent temperature integrity maintenance is needed at all levels.


Vaccination is one of the most cost-effective public health interventions in twenty-first century [1]. Vaccines are averting millions of deaths and sequelae due to diseases globally and have achieved smallpox eradication, poliomyelitis control and now aiming for measles eradication. Vaccines are temperature sensitive products and requires storage within narrow temperature range (usually 2-8 °C) during storage and transfers to preserve potency [2]. Some vaccines like oral polio vaccine (OPV) and rotavirus vaccine may be stored at -20 °C at bulk stores [3]. All vaccines are usually damaged by cumulative exposure to temperatures above + 8 °C. Vaccine vial monitor (VVM) containing a heat-sensitive material indicate the cumulative heat exposure and guide use of the vaccine. Exposure to freezing temperatures (< 0 °C) is equally damaging for the freeze-sensitive vaccines like diphtheria-pertussis-tetanus (DPT), liquid pentavalent vaccine (LPV), tetanus toxoid (TT), hepatitis A and B, human papillomavirus (HPV), meningitis C, pneumococcal conjugate vaccine (PCV), cholera, influenza, haemophilus influenza b (Hib), and inactivated poliovirus (IPV) making them inactive [4]. Apart from losing potency, administration of frozen vaccines may cause some adverse events [3]. Detection of exposure to freezing is challenging, as there is no marker currently available and the shake test is not commonly practiced by cold chain handlers and vaccinators [5, 6]. For shake test, the vaccine vial is vigorously shaken and placed inverted on a flat surface and examined for the physical changes, and the extent of sedimentation after 30 min. The presence of granular forms or floccules when shaking, or the formation of a sediment at the bottom of the container within 30 min, with clear liquid above, suggest that the vaccine has been frozen [7, 8]. The Universal Immunization Programme (UIP) of India targets about 26 million infants, 100 million children aged 1–5 years and 30 million pregnant women annually [3]. The UIP currently delivers vaccines against 13 vaccine-preventable diseases to children and pregnant women [3]. The cold chain in India is a five-tier storage system with about 26,388 cold chain points or vaccine stores (VSs), including the government medical supply depots (GMSDs) (n = 4), state VSs (n = 53), divisional VSs (n = 110), district VSs (n = 666) and the sub-district VSs (n = 25,555) at community health centers (CHCs) and primary health centers (PHCs) [9]. At the GMSDs, the vaccines are stored in cold rooms, walk-in coolers (WICs) and walk-in freezers (WIFs). At state and division VSs, the vaccines are usually stores in WICs, ice-lined refrigerators (ILRs) and WIFs. At district and sub-district (CHCs and PHCs) VSs, the vaccines are stored in ILRs. The cold rooms, WICs and ILRs are expected to maintain the optimum temperature (+ 2 to + 8 °C) for vaccine storage. The WIFs and deep freezers (DFs) are expected to maintain the optimum temperature (− 15 to -25 °C) for long-term vaccine storage. The vaccines are transferred in cold boxes of various sizes (between the VSs) and vaccine carriers (to outreach sessions) with icepacks to maintain temperature in + 2 to + 8 °C range. The vaccines and related supplies are handled by cold chain handlers at the cold chain points. The cold chain equipment are maintained by cold chain technicians.

Several studies from India reported exposure of vaccines to high temperatures [10,11,12]. The literature reported exposure of vaccines to freezing temperatures at vaccine stores for 10–33.7% in developing countries and 6.4–22.5% in developed countries [13, 14]. In India, a study across ten states informed about frequent exposure of the vaccines to freezing temperature at state compared to district, division and sub-district VSs [15]. This study was conducted to assess the available cold chain space and vaccine temperature integrity in three states of India for new vaccine introduction. This paper presents the data related to the temperature integrity at the cold chain points.


Study design and setting

This cross-sectional study was undertaken in three states of India: Bihar, Gujarat and Kerala during 2014–15. The states were purposively selected representing three different levels of routine immunization coverage (lowest, Bihar 49%, moderate, Gujarat 56.6% and highest, Kerala 81.5% according to Coverage Evaluation Survey 2009), governance and geography [16]. In each state one-third districts were included. Thus, in Bihar, 13 of 38 districts, in Gujarat, 9 of 26 districts and in Kerala, 5 of 14 districts were randomly selected, ensuring at least one district per division. In each selected district, seven VSs were selected through a multistage process based on distance from the district VS, as shown in Fig. 1. The state and district immunization program teams were consulted for selection of the districts and facilities in the districts. Additionally, in each state, all the division and state VSs were included and the WIC and ILR (used for vaccine storage) were selected for temperature monitoring.

Fig. 1

Process of selection of facilities and cold chain devices in the states and study districts

Temperature recording at stores

The study followed WHO protocol for temperature monitoring in the vaccine cold chain [17]. We used LogTag-Trix8 data loggers (range -40 °C to + 85 °C; precision ±0.5 °C) to record the temperatures (LogTag Recorders, Auckland, New Zealand) every 15 min [18]. The data logger battery and memory could record 8000 readings continuously. Temperature monitoring units (n = 145) containing one datalogger and two DPT vials (shake test negative) were placed inside the WICs, ILRs and others devices storing the vaccines at these facilities for at least 1 week. The research staff installed and removed the dataloggers for each device. For each cold chain device, the datalogger ID, installation and removal time, position of the data logger, thermometer availability, ice deposit on walls, gasket and door seal status at installation and removal were documented. The temperature chart recorded by cold chain handler (for the 1 week observation period and past 3 months) and verifications by the medical officer in-charge (from the registers) were documented at the time of logtag removal. One freeze sensitive vaccine (DPT/TT/HBV/LPV) from each box stored in the ILR and each rack of WIC (2–3 per ILR/WIC) were checked for freezing by shake test. All the dataloggers were transported to central coordinating office along with the filled data forms. The readings from the data loggers were downloaded using the dedicated software and exported into excel, which contained date and time stamp for each temperature record.

Data analysis

The first and last data points for the data loggers were excluded, as these might be representing the environmental temperature at placement and removal time. The exposure of vaccines to temperatures < 0 °C, ≥0 °C to < 2 °C, ≥2 °C to ≤8 °C and > 8 °C as proportions of observation period were estimated. Lower post-immunization IgG responses to the DTP vaccines (both acellular and whole cell pertussis antigens) in murine model has been reported on exposure to freezing at − 3 °C for 24 h [19]. Thus, the exposure to temperatures < 0 °C were further segregated to <− 3 °C and ≥ − 3 °C to 0 °C to document the risk of freezing. It was observed that after opening of the ILRs (with the logtags inside), the temperature increased and reached to preopening range after 15–30 min. Thus continuous episodes (periods with more than two consecutive readings by a data logger in the same range, for ≥45 min) of temperature excursion (remaining below 0 °C or above 8 °C), segregated for different durations (<1 h, > 1–9 h and ≥ 10 h) were also calculated. The duration of temperature maintenance in the devices were estimated for different types of devices (WICs, ILRs and others) and levels of vaccine stores (state, division, district and sub-district). The data for state and division VSs were pooled, as there was no state store in Gujarat and Kerala. Descriptive statistics measures were calculated using Microsoft Excel and STATA version 12 (StataCorp LLC, Texas, USA).


Administrative approvals from the appropriate national and state health authorities and ethical approval from INCLEN institute ethics committee (protocol no IIEC-006) were obtained.


The temperature recordings from 196 facilities and 218 devices were received. The recordings from 5 ILRs (from 3 PHCs and 2 District VSs) were less than 7 complete days and excluded from analysis. The temperature records for 59,039 h from 213 devices from 191 facilities were analysed. Table 1 shows the distribution of the types of facilities and devices. At 4 PHCs, non-ILR devices (domestic refrigerator, n = 1 and cold boxes, n = 3) were used for vaccine storage, due to temporary breakdown of ILRs.

Table 1 Description of vaccine stores and cold chain devices included for temperature monitoring

Temperature maintenance at vaccine stores

As shown in Table 2, during the observation period, 75.4% (95% CI: 60.8, 89.1%) of the state and division VSs; 71.1% (95% CI: 55.6, 83.1%) of the district VSs and 56.7% (95% CI: 50.2, 63.1%) of the sub-district (CHCs/PHCs) VSs maintained temperature in the desired range. The temperature dipped to sub-zero range for 8.5% (95% CI: 1, 17.1%), 7.4% (95% CI: 6.3, 8.4%) and 17.7% (95% CI: 11.9, 22%) of the observation period at the state/division, district and sub-district VSs respectively. The temperature also crossed above 8 °C in 5.2% (95% CI: 1, 11.3%), 10.1% (95% CI: 3.8, 16.3%) and 5.4% (95% CI: 5.1, 5.6%) of the observation period at the state/division, district and sub-district VSs respectively. The temperature fluctuated widely, from -33 °C to + 35 °C in the devices. The temperature deviation to both extremes (< 0 °C and > 8 °C) was observed at 19.7% of the devices (state/division- 15%, district- 12.9% and sub-district- 21.9%). The vaccines were exposed to sub-zero temperatures for longer period at the state/division and sub-district VSs and pooled for all levels, than exposure to > 8 °C. The vaccines spent sizable proportions of time at <− 3 °C (freezing temperature for many freeze-sensitive vaccines) at all levels of facilities (2.9 to 7.2%) and in all types of devices (0.4 to 6.7%), more in Bihar (8.5%). The vaccines stored in non-standard cold chain devices (domestic refrigerators/cold boxes) were exposed to > 8 °C for 55% of the observation period.

Table 2 Temperature integrity in cold chain devices according to type of vaccine stores

Continuous episodes of temperature excursion

The continuous temperature excursion episodes were observed at all levels of VSs, as reflected in Table 3. The pooled continuous episodes (≥45 min) constituted to 14.8% of the temperature excursion to the sub-zero temperature ranges. The proportion of continuous excursion episodes were higher in the devices at all levels in Bihar; 13.1% at state/division, 12.9% at districts and 19.7% at sub-district VSs, which were higher than Gujarat and Kerala. The continuous excursion episodes to sub-zero temperature at the sub-district VSs in Gujarat were also high (19.9%).

Table 3 Continuous episodes of temperature excursion below 0 °C in cold chain devices

As shown in Table 4, the pooled continuous excursion episodes constituted 6.6% of the temperature excursion duration to > 8 °C range. The continuous excursion episodes to > 8 °C were higher in Bihar (6.6%) than Gujarat and Kerala. The continuous excursion episodes in Bihar were higher at district (25.5%) followed by state/division (7.4%) and sub-district level VSs (7.8%).

Table 4 Continuous episodes of temperature excursion above 8 °C in cold chain devices

Routine temperature monitoring practices

At the state/division VSs, 76% of the WICs (Bihar-63.6%, Gujarat-90% and Kerala-75%) and 71.4% of ILRs (Bihar-72.7%, Gujarat-80% and Kerala- 61.5%) had functional temperature monitors at the time of observation. The functional thermometers were available in 83.6% (Bihar-76.3%, Gujarat-74.6% and Kerala-100%) of ILRs at district VSs and 97% (Bihar-94.7%, Gujarat-100% and Kerala-96.4%) of ILRS at sub-district VSs. The temperature logbook was available at all state/division, 81.7% of the district (Bihar-81.8%, Gujarat-83.3% and Kerala-80%) and 84.5% of the sub-district VSs (Bihar-66.5%, Gujarat-92.6% and Kerala-94.3%). From the temperature logbooks, deviation in temperature (< 2 °C/> 8 °C) for the observation period (period of logtag installation) was observed in only 5.6% of devices (Bihar, n = 7; Gujarat, n = 4 and Kerala, n = 1). According to the logbooks, deviations in temperature to < 2 °C or > 8 °C were observed at 5.8% facilities (Bihar, n = 7; Gujarat, n = 3 and Kerala, n = 4) during 3 months prior to the survey. Weekly supervision of temperature logbook by the in-charge officer (bearing signature) was observed at 24.1% facilities and at least one supervision was done at 29.6% facilities within last 1 month. Gaskets were not fitting/damaged in 23.3% of the devices and ice layer > 5 mm was observed in 2% ILRs. The documentation for preventive maintenance of the devices were not available at most (85%) of the facilities, more at the district and sub-district level.

Frozen freeze sensitive vaccine vials were observed in 12 PHCs in Bihar (from 5 districts), 7 PHCs in Gujarat (from 3 districts) and 6 CHCs/PHCs in Kerala (from 4 districts). The study team didn’t check the all the vaccine vials in the ILRs/WICs for freezing or damage. No vaccine vial was discarded due to freezing or damage at any of the surveyed facilities (VSs) as per the store records.


Immunization is a critical component of the Government of India’s child survival strategy, elimination and control of vaccine preventable diseases (maternal and neonatal tetanus, poliomyelitis, measles, etc.) and achieving sustainable development goal of ending preventable deaths of newborn and under-five children by 2030. In 2017, India’s immunization budget was estimated to 1480 million USD which has almost doubled compared to 2012 (around 700 million USD). The share of vaccine cost has increased from 11% in 2012 to 38% in 2017 (around 560 million USD) with introduction of the new vaccines [20]. Maintenance of optimal cold-chain system across all levels is inevitable to ensure administration of good quality and potent vaccines to each child or woman in the country.

During the observation period, temperature excursion outside + 2 to + 8 °C range was documented for sizable proportion of storage times (24.6 to 43.9%) at all levels. Temperature excursions to both extremes of temperature range, < 0 °C and > 8 °C were observed at all levels. The vaccines were exposed to continuous episodes of temperature excursion, longer to < 0 °C range (14.8%) than to > 8 °C range (6.6%). The exposure to sub-zero temperature at the state/division vaccine stores was worrisome in view of the duration exposure, continuous episodes and bulk storage of vaccines for longer period. The reasons for higher temperature excursions observed in devices in one state (Bihar) were not clearly known.

Another study from India (10 states; 131 facilities) reported exposure of vaccines to > 8 °C for 8.3–14.7% (14.3, 13.2, 8.3 and 14.7% for state, divisional, district and sub-district vaccine stores respectively) and to below 0 °C for 0.2–10.5% (1.5, 0.2, 0.6 and 10.5% for state, divisional, district and sub-district vaccine stores respectively). While state stores in eight states documented excursion to > 8 °C temperature (0–83.3%), only one state (Tamil Nadu) experienced excursion to sub-zero temperature (10.7%). The exposure to sub-zero temperature (10.5%) was comparable that for > 8 °C (14.7%) at sub-district stores. Continuous episodes constituted majority of the temperature deviations; about 85 and 94% of the exposure to temperatures of < 0 °C and > 8 °C respectively [15]. The two states (Bihar and Gujarat) were common with the current study. At state/division level stores, the vaccines were exposed to > 8 °C for 16.6 and 0.5% of observation periods respectively. In Bihar, at district and sub-district level stores, the vaccines were exposed to > 8 °C for 49 and 39.5% of observation periods respectively. No temperature excursion was observed at district levels stores in Gujarat. The vaccines were exposed to sub-zero temperature for 2.6 and 11.6% of observation period in Bihar and Gujarat respectively. Several other studies also reported temperature integrity challenges at vaccine stores and outreach levels in India [10,11,12, 21, 22].

Review of articles (14 studies; during 1985–2006) summarized that at storage level, 21.9% (95% CI: 10.3–33.6%) refrigerators in developing countries were exposed to freezing temperature compared to 13.5% (95% CI: 6.4–20.7%) in developed countries [13, 23,24,25]. A follow up review of articles (18 studies including 8 from developing countries and 10 from developed countries; during 2006–2014) documented that at storage level, 37.1% (SD: 29.7) of the refrigerators in developing countries and 33.3% (SD: 22.5) in developed countries [14, 15, 26,27,28]. These two reviews indicate persistence of the temperature excursion at the vaccine storage points, despite the possible variations in study methodologies and rigors. The practices of manual temperature monitoring were not able to capture these temperature excursions. According to reports, the practice of detection of freezing by shake test for freeze-sensitive vaccines had been suboptimal, both at vaccine stores (22.4%) and vaccination sites (8.6%) [6, 21, 29].

The stability and potency of vaccines are generally temperature-sensitive. Effect of vaccine exposure to higher temperature is usually cumulative and can alter the protein structure and/or chemical stability leading to loss of potency. VVM indicates the cumulative exposure to heat (duration * degree of heat). Exposure of freeze-sensitive vaccines to sub-zero temperatures cause dissociation of antigen from adjuvants, conglomeration of the aluminium salt adjuvants, and the granule size increase with repeated freeze-thaw cycles [8, 30]. Administration of frozen DPT and TT vaccines are more likely to cause local reactions [30, 31]. Exposure of DPT vaccines to freeze-thaw cycles have demonstrated progressive drop in potency with number of cycles [32]. Instances of vaccine failure and suboptimal population immunity with vaccination with the frozen freeze-sensitive less potent vaccines has been reported for hepatitis B in Mongolia and pertussis in USA [33, 34].

This study documented the temperature integrity and occurrence of excursions at the vaccine stores of all levels in the three states. These temperature excursions were not captured by the routine manual temperature monitoring. The issues emerged that require attention for safe storage of the vaccines were: lack of routine maintenance practices including defrosting, thermostat setting according to ambient temperature, irregular power supply, shortages of trained and dedicated personnel, calibration of thermometers and periodic supervision to ensure cold chain maintenance, especially at the sub-district levels. It may be important to assess the impact of temperature deviations and continuous episodes on freezing and damage of the vaccine vials in the WICs/ILRs in future studies.

The recent efforts of Government of India on Electronic Vaccine Intelligence Network (eVIN) is a step towards ensuring vaccine temperature integrity at cold chain stores [35]. The eVIN system is being expanded in a phased manner in India. Efforts towards training of the cold chain handlers are also being undertaken. Also till eVIN is implemented universally, availability of functional thermometer in all cold chain devices and appropriate documentation are to be ensured. Apart from the stringent temperature monitoring, capacity building of the dedicated cold chain handlers and technicians for routine device maintenance, ensuring appropriate power supply, suitable voltage stabilizers and regular supervision and monitoring are needed to ensure cold chain integrity, especially at the district and sub-district levels.

Our study has certain limitations. We did not use additional freeze alert to indicate freezing. Shake test was not done for all the eligible vaccine vials. Shake test was done for the vaccine vials from the devices only once, at the time of LogTag removal, thus might not inform about the past freezing exposures. The potency of vaccines exposed to either higher or lower temperatures was not tested.


The study documented that vaccines were exposed to freezing temperature for a considerable period at all level stores and the exposure duration was more than that to the higher temperature. These sub-zero temperature excursions were not captured by the routine manual temperature monitoring and indicated by any VVM like indicator. Exposure of the freeze-sensitive vaccines to sub-zero temperature can affect the vaccine potency and reduce effectiveness. To ensure vaccine potency and immunogenicity, stringent temperature integrity maintenance is needed at all levels. There is need for refresher capacity building of cold chain handlers and store in-charges in preventive device maintenance, ensuring periodic physical audits and systematic supportive supervision.

Availability of data and materials

The data used to support the findings of this study can be obtained from the corresponding author on request.



Community health center


Confidence interval


Deep freezer




Electronic Vaccine Intelligence Network


Government medical supply depots


Hepatitis B


Haemophilus influenza b


Human papillomavirus


Ice-lined refrigerator


Inactivated poliovirus


Low and middle income countries


Liquid pentavalent vaccine


Oral poliovirus vaccine


Pneumococcal conjugate vaccine


Primary health center


Standard deviation


Tetanus toxoid


Universal immunization program


United States Dollar


Vaccine vial monitor


World health organization


Walk-in cooler


Walk-in freezer


  1. 1.

    Center for Disease Control. CDC. Ten great public health achievements — United States, ten great achievements — United States. MMWR Morb Mortal Wkly Rep. 1999;48:243–8 Available from:

    Google Scholar 

  2. 2.

    Yakum MN, Ateudjieu J, Pélagie FR, Walter EA, Watcho P. Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon. BMC Res Notes. 2015;8(1) Available from: Cited 1 Mar 2018.

  3. 3.

    Ministry of Health and Family Welfare, Government of India. Immunization Handbook for Medical Officers. New Delhi: Ministry of Health & Family Welfare Government of India; 2016. Cited 1 Mar 2018.

  4. 4.

    World Health Organisation. WHO vaccine management handbook. Module VMH-E2-01.1. How to monitor temperatures in the vaccine supply chain: World Health Organisation; 2015. Available from: Cited 20 Feb 2018.

  5. 5.

    National Cold Chain Vaccine Management Resource Center (NCCVMRC). National Effective Vaccine Management Assessment, India (2013): National Institute of Health & Family Welfare, India; 2013. Available from:,%202013.pdf. Cited 1 Mar 2018.

  6. 6.

    Choudhury SA, Ojah J. A study on knowledge and practice of immunization services among auxiliary nurse midwives of subcentre at Chirang district. Assam J Evid Based Med Healthc. 2016;3(16):618–21.

    Article  Google Scholar 

  7. 7.

    World Health Organization. Temperature sensitivity of vaccines. Geneva: World Health Organization; 2006. Available from:

    Google Scholar 

  8. 8.

    Kartoglu Ü, Özgüler NK, Wolfson LJ, Kurzatkowski W. Validation of the shake test for detecting freeze damage to adsorbed vaccines. Bull World Health Organ. 2010;88(8):624–31.

    Article  Google Scholar 

  9. 9.

    Unicef. National cold chain assessment India (2014). India: Unicef, Country Office; 2014. Available from: Cited 1 Mar 2018.

    Google Scholar 

  10. 10.

    Samant Y, Lanjewar H, Parker D, Block L, Tomar GS, Stein B. Evaluation of the cold-chain for oral polio vaccine in a rural district of India. Public Health Rep Wash DC 1974. 2007;122(1):112–21.

    Google Scholar 

  11. 11.

    Galhotra A, Goel NK, Pathak R, Kumar R, Swami HM. Surveillance of cold chain system during intensified pulse polio programme--2006 in Chandigarh. Indian J Pediatr. 2007;74(8):751–3.

    Article  Google Scholar 

  12. 12.

    Goel NK, Pathak R, Galhotra A, Dankal C, Swami HM. Status of cold-chain maintenance in Chandigarh. Indian J Public Health. 2008;52(1):37–9.

    CAS  PubMed  Google Scholar 

  13. 13.

    Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007;25(20):3980–6.

    CAS  Article  Google Scholar 

  14. 14.

    Hanson CM, George AM, Sawadogo A, Schreiber B. Is freezing in the vaccine cold chain an ongoing issue? A literature review. Vaccine. 2017;35(17):2127–33.

    Article  Google Scholar 

  15. 15.

    Murhekar MV, Dutta S, Kapoor AN, Bitragunta S, Dodum R, Ghosh P, et al. Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states. Bull World Health Organ. 2013;91(12):906–13.

    Article  Google Scholar 

  16. 16.

    Ministry of Health and Family Welfare (MOHFW), ORG Centre for Social Research (ORG CSR), United Nations Children’s Fund (UNICEF). India coverage evaluation survey: United Nations Children’s Fund (UNICEF); 2009. Available from: Cited 12 Apr 2013.

  17. 17.

    World Health Organization. Study protocol for temperature monitoring in the vaccine cold chain. Geneva: World Health Organization. Department of Immunization, Vaccines and Biologicals. World Health Organization; 2011. Available from:

    Google Scholar 

  18. 18.

    LogTag Recorders. LogTag® TRIX-8 Data logger. Bell Technology Ltd. Available from: Cited 2 Mar 2018.

  19. 19.

    Boras C, Hanlon M, Gold M, Robertson D. Storage at −3 degrees C for 24 hours alters the immunogenicity of pertussis vaccines. Vaccine. 2001;19(25–26):3537–42.

    Article  Google Scholar 

  20. 20.

    Chatterjee S, Pant M, Haldar P, Aggarwal M, Laxminarayan R. Current costs & projected financial needs of India’s universal immunization programme. Indian J Med Res. 2016;143(6):801.

    Article  Google Scholar 

  21. 21.

    Rao S, Naftar S, Baliga S, Unnikrishnana B. Evaluation, awareness, practice and management of cold chain at the primary health care centers in coastal South India. J Nepal Paediatr Soc. 2012;32(1) Available from: Cited 3 Mar 2018.

  22. 22.

    Pakhare A, Bali S, Pawar R, Lokhande G. Assessment of cold-chain maintenance in vaccine carriers during Pulse Polio National Immunization Day in a rural block of India. WHO South-East Asia J Public Health. 2014;3(2):190.

    Article  Google Scholar 

  23. 23.

    Hanjeet K, Lye MS, Sinniah M, Schnur A. Evaluation of cold chain monitoring in Kelantan. Malaysia Bull World Health Organ. 1996;74(4):391–7.

    CAS  PubMed  Google Scholar 

  24. 24.

    Bell KN, Hogue CJ, Manning C, Kendal AP. Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics. 2001;107(6):E100.

    CAS  Article  Google Scholar 

  25. 25.

    Gazmararian JA, Oster NV, Green DC, Schuessler L, Howell K, Davis J, et al. Vaccine storage practices in primary care physician offices: assessment and intervention. Am J Prev Med. 2002;23(4):246–53.

    Article  Google Scholar 

  26. 26.

    Techathawat S, Varinsathien P, Rasdjarmrearnsook A, Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine. 2007;25(7):1328–33.

    CAS  Article  Google Scholar 

  27. 27.

    Carr C, Julie B. Durrheim. Practice nurses best protect the vaccine cold chain in general practice. Austr J Adv Nurs. 2009;27(2):35–9.

    Google Scholar 

  28. 28.

    Adeel A, Syed BSN, Azfar I, Osama S. Temperature monitoring of vaccines’ storage compartments in different health centres and pharmacies at Karachi. Pak Int J. 2014;5(3):984–8.

    Google Scholar 

  29. 29.

    National Cold Chain Vaccine Management Resource Center (NCCVMRC). National effective vaccine management assessment, India (2013): National Institute of Health & Family Welfare; 2013. Available from:,%202013.pdf Cited 20 Feb 2018.

  30. 30.

    Milstien J, Kartoglu U, Zaffran M. Temperature sensitivity of vaccines: World Health Organisation; 2006. Available from: Cited 3 Mar 2018.

  31. 31.

    Hibbs BF, Miller E, Shi J, Smith K, Lewis P, Shimabukuro TT. Safety of vaccines that have been kept outside of recommended temperatures: reports to the vaccine adverse event reporting system (VAERS), 2008–2012. Vaccine. 2018;36(4):553–8.

    Article  Google Scholar 

  32. 32.

    PATH. Effects of freezing on vaccine potency. Literature review: PATH; 2003. Available from: Cited 3 Mar 2018.

  33. 33.

    Davaalkham D, Ojima T, Wiersma S, Lkhagvasuren T, Nymadawa P, Uehara R, et al. Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey. J Epidemiol Community Health. 2007;61(7):578–84.

    Article  Google Scholar 

  34. 34.

    McColloster P, Vallbona C. Graphic-output temperature data loggers for monitoring vaccine refrigeration: implications for pertussis. Am J Public Health. 2011;101(1):46–7.

    Article  Google Scholar 

  35. 35.

    Ministry of Health and Family Welfare, United Nations Development Program. Improving efficiency of vaccination systems in multiple states. United Nations Development Program. Available from: Cited 28 Apr 2018.

Download references


We are grateful to Immunization Division, Government of India, Departments of Health and Family Welfare, Kerala, Gujarat and Bihar for providing the opportunity to undertake this project in the respective states. We highly appreciate the support from the health functionaries and health administration of the districts in the three states for implementing the project activities. We highly acknowledge the data collection teams from partner medical colleges under leadership of Dr. Ashok Kumar, Darbhanga Medical College, Darbhanga, Bihar; Dr. C B Kumar, Patna Medical College, Patna, Bihar; Dr. Arvind Kumar, S. K. Medical College, Muzaffarpur, Bihar; Dr. Ayan Ghosh, Katihar Medical College, Katihar, Bihar; Dr. Sudha Yadav, M P Shah Medical College, Jamnagar, Gujarat; Dr. V S Mazumdar, Govt. Medical College, Vadodara, Gauarat; Dr. Geeta Kedia, BJ Medical College, Ahmedabad, Gujarat; Dr. S L Kantharia, Government Medical College, Surat, Gujarat; Dr. Uday Shankar Singh, PS Medical College, Karamsad, Gujarat; Dr. A Sobha, Government Medical College, Kottayam, Kerala; Dr. Jose Joseph, Government Medical College, Alappuzha, Kerala; Dr. Thomas Bina, Government Medical College, Kozhikode, Kerala; Dr. C Prabhakumari, Government Medical College, Kozhikode, Kerala; Dr. Sara Varghese, Government Medical College, Thiruvananthapuram, Kerala; Dr. Lucy Raphel, Government Medical College, Thrissur, Kerala; and Dr. Usha Karunakaran, and Dr. Jayashree A K, Academy of Medical Sciences, Pariyaram, Kerala.


This project was supported by the Bill and Melinda Gates Foundation for funding this project [grant number OPP1041395].

Author information




MKD and NKA conceptualised the framework for the study protocol, training, data analysis and interpretation. TM, BV and AY coordinated the field data collection. MKD, SKD and AY analysed the data. MKD wrote the first draft of the manuscript. All authors read, provided critical input and approved the final manuscript.

Corresponding author

Correspondence to Manoja Kumar Das.

Ethics declarations

Ethics approval and consent to participate

The study protocol was reviewed and approved by INCLEN Ethics Committee (Ref: IIEC 06). There was no personal data collected from any patient or individual under the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that there is no competing financial or non-financial interests or conflict of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Das, M.K., Arora, N.K., Mathew, T. et al. Temperature integrity and exposure of vaccines to suboptimal temperatures in cold chain devices at different levels in three states of India. Trop Dis Travel Med Vaccines 6, 8 (2020).

Download citation


  • Cold chain
  • Vaccines
  • Temperature maintenance
  • Temperature excursion
  • Freezing
  • Datalogger